Investments in Other Entities (Tables)

12 Months Ended

Dec. 31, 2024

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments

For the years ended December 31, 2024 and 2023, the Company’s equity method investment balance consisted of the following (in thousands):

	% of Ownership	December 31, 2023		Initial Investment		Allocation of Net Income (Loss)			December 31, 2024
LaSalle Medical Associates    – IPA Line of Business	25%	$	9,866	$	—	$	3,262		$	13,128
Pacific Medical Imaging & Oncology Center, Inc.	40%		1,691		—		(31	)		1,660
CAIPA MSO, LLC	30%		13,660		—		952			14,612
I Health, Inc.	25%		—		5,968		109			6,077
Other *	25% - 51%		557		3,126		159			3,842
		$	25,774	$	9,094	$	4,451		$	39,319

*Other consists of smaller equity method investments including those from the CHS acquisition.

	% of Ownership	December 31, 2022		Initial Investment		Allocation of Net Income (Loss)			Funding		Adjustment of Fair Value**		Distribution			December 31, 2023
LaSalle Medical Associates    – IPA Line of Business	25%	$	5,684	$	—	$	4,182		$	—	$	—	$	—		$	9,866
Pacific Medical Imaging & Oncology Center, Inc.	40%		1,878		—		(187	)		—		—		—			1,691
531 W. College, LLC **	50%		17,281		—		(508	)		700		91		(17,564	)		—
One MSO, LLC **	50%		2,718		—		938			—		3,260		(6,916	)		—
CAIPA MSO, LLC	30%		12,738		—		922			—		—		—			13,660
Other *	25%		—		325		232			—		—		—			557
		$	40,299	$	325	$	5,579		$	700	$	3,351	$	(24,480	)	$	25,774

* Other consists of smaller equity method investments.

** Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off (see Note 20—“Segments”).